| GWAS |
- Adverse response to lamotrigine and phenytoin ( 22379998)
- Attention function in attention deficit hyperactive disorder ( 26174813)
- Blood protein levels ( 29875488)
- Bone mineral density change response to combined chemotherapy in acute lymphoblastic leukemia ( 29266176)
- Cannabis use (initiation) ( 22823124)
- Cellular nuclear factor (erythroid-derived 2)-like 2 levels ( 30767168)
- Chronic periodontitis (mean interproximal clinical attachment level) ( 27601451)
- Crohn's disease ( 17684544)
- Fibrinogen levels (smoking status, alcohol consumption or body mass index interaction) ( 25551457)
- Hepcidin levels ( 27846281)
- Hepcidin/transferrin saturation ratio ( 27846281)
- Hippocampal sclerosis ( 25188341)
- Methadone dose in opioid dependence ( 28115739)
- Obesity-related traits ( 23251661)
- Prudent dietary pattern ( 28644415)
- Response to amphetamines ( 22952603)
- Response to long-chain n-3 polyunsaturated fatty acid supplementation (change in triglyceride levels) ( 24847101)
- Triglyceride levels in HIV infection ( 33109212)
- Weight ( 28552196)
|
- Anorexia nervosa, attention-deficit/hyperactivity disorder, autism spectrum disorder, bipolar disorder, major depression, obsessive-compulsive disorder, schizophrenia, or Tourette syndrome (pleiotropy) ( 31835028)
- Brain morphology (min-P) ( 32665545)
- Brain morphology (MOSTest) ( 32665545)
- Cataracts ( 34127677)
- Cortical surface area (MOSTest) ( 32665545)
- Diastolic blood pressure ( 30224653)
- Estimated glomerular filtration rate ( 31152163)
- Red cell distribution width ( 32888494)
- Refractive error ( 32231278)
- Schizophrenia ( 28991256 25056061 29483656)
- Subcortical volume (min-P) ( 32665545)
- Subcortical volume (MOSTest) ( 32665545)
- Type 2 diabetes ( 30054458)
|